Cargando…

Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report

BACKGROUND: Primary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findings that can be classified in the known pathologies of mitochondrial deletion s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ewert, Ralf, Elhadad, Mohamed A., Habedank, Dirk, Heine, Alexander, Stubbe, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061947/
https://www.ncbi.nlm.nih.gov/pubmed/36991405
http://dx.doi.org/10.1186/s12890-023-02391-x
_version_ 1785017396806811648
author Ewert, Ralf
Elhadad, Mohamed A.
Habedank, Dirk
Heine, Alexander
Stubbe, Beate
author_facet Ewert, Ralf
Elhadad, Mohamed A.
Habedank, Dirk
Heine, Alexander
Stubbe, Beate
author_sort Ewert, Ralf
collection PubMed
description BACKGROUND: Primary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findings that can be classified in the known pathologies of mitochondrial deletion syndrome. CASE PRESENTATION: The patient presented to us at 29 years of age, having had tachycardia, dyspnea, and functional impairment since childhood. She had been diagnosed with bronchial asthma and mild left ventricular hypertrophy and treated accordingly, but her symptoms had worsened. After more than 20 years of progressive physical and social limitations was a mitochondrial disease suspected in the exercise testing. We performed cardiopulmonary exercise testing (CPET) with right heart catheterization showed typical signs of mitochondrial myopathy. Genetic testing confirmed the presence of a ~ 13 kb deletion in mitochondrial DNA from the muscle. The patient was treated with dietary supplements for 1 year. In the course of time, the patient gave birth to a healthy child, which is developing normally. CONCLUSION: CPET and lung function data over 5 years demonstrated stable disease. We conclude that CPET and lung function analysis should be used consistently to evaluate the cause of dyspnea and for long-term observation.
format Online
Article
Text
id pubmed-10061947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100619472023-03-31 Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report Ewert, Ralf Elhadad, Mohamed A. Habedank, Dirk Heine, Alexander Stubbe, Beate BMC Pulm Med Case Report BACKGROUND: Primary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findings that can be classified in the known pathologies of mitochondrial deletion syndrome. CASE PRESENTATION: The patient presented to us at 29 years of age, having had tachycardia, dyspnea, and functional impairment since childhood. She had been diagnosed with bronchial asthma and mild left ventricular hypertrophy and treated accordingly, but her symptoms had worsened. After more than 20 years of progressive physical and social limitations was a mitochondrial disease suspected in the exercise testing. We performed cardiopulmonary exercise testing (CPET) with right heart catheterization showed typical signs of mitochondrial myopathy. Genetic testing confirmed the presence of a ~ 13 kb deletion in mitochondrial DNA from the muscle. The patient was treated with dietary supplements for 1 year. In the course of time, the patient gave birth to a healthy child, which is developing normally. CONCLUSION: CPET and lung function data over 5 years demonstrated stable disease. We conclude that CPET and lung function analysis should be used consistently to evaluate the cause of dyspnea and for long-term observation. BioMed Central 2023-03-29 /pmc/articles/PMC10061947/ /pubmed/36991405 http://dx.doi.org/10.1186/s12890-023-02391-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Ewert, Ralf
Elhadad, Mohamed A.
Habedank, Dirk
Heine, Alexander
Stubbe, Beate
Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report
title Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report
title_full Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report
title_fullStr Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report
title_full_unstemmed Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report
title_short Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report
title_sort primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation – a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061947/
https://www.ncbi.nlm.nih.gov/pubmed/36991405
http://dx.doi.org/10.1186/s12890-023-02391-x
work_keys_str_mv AT ewertralf primarymitochondrialdiseaseasararecauseofunclearbreathlessnessanddistinctiveperformancedegradationacasereport
AT elhadadmohameda primarymitochondrialdiseaseasararecauseofunclearbreathlessnessanddistinctiveperformancedegradationacasereport
AT habedankdirk primarymitochondrialdiseaseasararecauseofunclearbreathlessnessanddistinctiveperformancedegradationacasereport
AT heinealexander primarymitochondrialdiseaseasararecauseofunclearbreathlessnessanddistinctiveperformancedegradationacasereport
AT stubbebeate primarymitochondrialdiseaseasararecauseofunclearbreathlessnessanddistinctiveperformancedegradationacasereport